Topics : Overview and update of the ProBio study, Scientific results from ProBio and presentations of experimental compounds, Result of the inclusion competition, PSMA-PET in metastatic prostate cancer, Clinical implementation of BRCA testing in Sweden and Future development of ProBio European Society For Medical Oncology – First results of the Prostate Biomarkers (ProBio) platform study demonstrate that, on average, androgen receptor pathway inhibitors outperform taxanes in all circulating tumour DNA